• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A method of determining intrinsic hepatic clearance from the first-pass effect.

作者信息

Bass L, Winkler K

出版信息

Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):339-43. doi: 10.1111/j.1440-1681.1980.tb00080.x.

DOI:10.1111/j.1440-1681.1980.tb00080.x
PMID:7398141
Abstract
  1. The relation between systemic hepatic clearance, intrinsic hepatic clearance and hepatic blood fow is considered from the point of view of the sinusoidal perfusion (parallel tube) model of the liver. 2. It is shown how intrinsic hepatic clearance may be calculated, for substrates eliminated in the liver and the kidney only, from data obtained by introducing successively an oral and an intravenous dose (i.e., by using the first-pass effect) with the clinically cumbersome catheterization of the liver vein. 3. The rate of hepatic blood flow is shown to follow from the same data.
摘要

相似文献

1
A method of determining intrinsic hepatic clearance from the first-pass effect.
Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):339-43. doi: 10.1111/j.1440-1681.1980.tb00080.x.
2
Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach.应用生理人群药代动力学建模方法研究儿童肠道和肝脏中咪达唑仑 CYP3A 介导的代谢特征。
Pharm Res. 2018 Jul 30;35(9):182. doi: 10.1007/s11095-018-2458-6.
3
Effects of route of administration and blood flow on hepatic drug elimination.给药途径和血流对肝脏药物消除的影响。
J Pharmacol Exp Ther. 1975 Dec;195(3):424-32.
4
Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.异黄酮衍生物依普黄酮在大鼠静脉注射和口服给药后的药代动力学:肝脏和肠道的首过效应
Life Sci. 2002 Feb 1;70(11):1299-315. doi: 10.1016/s0024-3205(01)01508-9.
5
Pharmacokinetic model of presystemic metabolism.首过代谢的药代动力学模型。
Drug Metab Dispos. 1978 Mar-Apr;6(2):193-6.
6
Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.通过胃肠转运吸收模型,对大鼠口服摄入啤酒中存在的胃泌素释放强效刺激剂N-甲基酪胺后的吸收情况进行分析和预测,包括其肝首过代谢。
Drug Metab Dispos. 2000 May;28(5):577-81.
7
Clinical significance of pharmacokinetic models of hepatic elimination.肝脏消除药代动力学模型的临床意义。
Clin Pharmacokinet. 1990 Jan;18(1):61-76. doi: 10.2165/00003088-199018010-00004.
8
Intestinal absorption and presystemic elimination of the prokinetic agent, EM574, in the rabbit.促动力剂EM574在兔体内的肠道吸收及首过消除
J Pharm Sci. 2002 Jan;91(1):217-28. doi: 10.1002/jps.10002.
9
Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.研究 HMG-CoA 还原酶抑制剂在大鼠和人体内肝消除的速率决定过程。
Drug Metab Dispos. 2010 Feb;38(2):215-22. doi: 10.1124/dmd.109.030254. Epub 2009 Oct 29.
10
Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.采用门静脉插管大鼠评估口服吸收过程中各种药物的肠道利用度。
Drug Metab Dispos. 2012 Dec;40(12):2231-8. doi: 10.1124/dmd.112.048223. Epub 2012 Aug 28.

引用本文的文献

1
A nonlinear physiologic pharmacokinetic model: I. Steady-state.一种非线性生理药代动力学模型:I. 稳态
J Pharmacokinet Biopharm. 1985 Feb;13(1):73-92. doi: 10.1007/BF01073657.
2
Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow.
Dig Dis Sci. 1987 Jul;32(7):753-8. doi: 10.1007/BF01296143.
3
Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships.基于定量构效关系预测巴比妥类药物静脉注射和口服给药后家兔的肝首过代谢及血浆水平。
J Pharmacokinet Biopharm. 1988 Jun;16(3):279-301. doi: 10.1007/BF01062138.
4
Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.维拉帕米和硝酸异山梨酯对肝硬化患者吲哚菁绿肝清除率无影响。
Br J Clin Pharmacol. 1990 Aug;30(2):221-7. doi: 10.1111/j.1365-2125.1990.tb03768.x.
5
Clinical significance of pharmacokinetic models of hepatic elimination.肝脏消除药代动力学模型的临床意义。
Clin Pharmacokinet. 1990 Jan;18(1):61-76. doi: 10.2165/00003088-199018010-00004.